JP7385603B2 - 組換えaav生成のためのアニオン交換クロマトグラフィー - Google Patents
組換えaav生成のためのアニオン交換クロマトグラフィー Download PDFInfo
- Publication number
- JP7385603B2 JP7385603B2 JP2020568998A JP2020568998A JP7385603B2 JP 7385603 B2 JP7385603 B2 JP 7385603B2 JP 2020568998 A JP2020568998 A JP 2020568998A JP 2020568998 A JP2020568998 A JP 2020568998A JP 7385603 B2 JP7385603 B2 JP 7385603B2
- Authority
- JP
- Japan
- Prior art keywords
- aav
- raav particles
- feed composition
- raav
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/16—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the fluid carrier
- B01D15/166—Fluid composition conditioning, e.g. gradient
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
- B01D15/361—Ion-exchange
- B01D15/363—Anion-exchange
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14123—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862684835P | 2018-06-14 | 2018-06-14 | |
| US62/684,835 | 2018-06-14 | ||
| PCT/US2019/037013 WO2019241535A2 (en) | 2018-06-14 | 2019-06-13 | Anion exchange chromatography for recombinant aav production |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021526829A JP2021526829A (ja) | 2021-10-11 |
| JP2021526829A5 JP2021526829A5 (cg-RX-API-DMAC7.html) | 2022-06-20 |
| JP7385603B2 true JP7385603B2 (ja) | 2023-11-22 |
Family
ID=67513723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020568998A Active JP7385603B2 (ja) | 2018-06-14 | 2019-06-13 | 組換えaav生成のためのアニオン交換クロマトグラフィー |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12070702B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3807405A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7385603B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102930150B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN112469822A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019285186B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3102817A1 (cg-RX-API-DMAC7.html) |
| IL (2) | IL319002A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019241535A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11015174B2 (en) | 2015-12-11 | 2021-05-25 | The Trustees Of The University Of Pennsylvania | Scalable purification method for AAV8 |
| EP3387138B2 (en) | 2015-12-11 | 2026-05-27 | The Trustees Of The University Of Pennsylvania | Scalable purification method for aav9 |
| EP3992283A1 (en) | 2015-12-11 | 2022-05-04 | The Trustees Of The University Of Pennsylvania | Scalable purification method for aavrh10 |
| IL319002A (en) * | 2018-06-14 | 2025-04-01 | Regenxbio Inc | Anion exchange chromatography for recombinant AAV production |
| WO2020033842A1 (en) | 2018-08-10 | 2020-02-13 | Regenxbio Inc. | Scalable method for recombinant aav production |
| ES2965341T3 (es) | 2019-04-11 | 2024-04-12 | Regenxbio Inc | Métodos de cromatografía de exclusión por tamaño para la caracterización de composiciones de virus adenoasociados recombinantes |
| JP7630443B2 (ja) | 2019-04-19 | 2025-02-17 | レジェンクスバイオ インコーポレーテッド | アデノ随伴ウイルスベクター製剤及び方法 |
| WO2021158915A1 (en) * | 2020-02-06 | 2021-08-12 | Precision Biosciences, Inc. | Recombinant adeno-associated virus compositions and methods for producing and using the same |
| WO2022032104A1 (en) * | 2020-08-07 | 2022-02-10 | Janssen Biotech, Inc. | Formulations for highly purified viral particles |
| CN116234619B (zh) * | 2020-08-18 | 2026-07-21 | 赛多利斯比亚分离有限责任公司 | 宿主细胞dna的金属亲和提取 |
| AU2021356684A1 (en) | 2020-10-09 | 2023-05-11 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of fabry disease |
| WO2022082109A1 (en) | 2020-10-18 | 2022-04-21 | The Trustees Of The University Of Pennsylvania | Improved adeno-associated virus (aav) vector and uses therefor |
| MX2023005113A (es) | 2020-10-29 | 2023-08-04 | Univ Pennsylvania | Cápsides de aav y composiciones que las contienen. |
| KR20230078805A (ko) * | 2020-11-02 | 2023-06-02 | 바이오마린 파머수티컬 인크. | 아데노-연관 바이러스의 농축 공정 |
| AU2021375404A1 (en) * | 2020-11-03 | 2023-06-08 | Pfizer Inc. | Methods for purification of aav vectors by anion exchange chromatography |
| EP4263841A1 (en) | 2020-12-16 | 2023-10-25 | REGENXBIO Inc. | Method of producing a recombinant adeno-associated virus particle |
| AU2022210592A1 (en) | 2021-01-21 | 2023-07-13 | Regenxbio Inc. | Improved production of recombinant polypeptides and viruses |
| CA3205744A1 (en) * | 2021-01-21 | 2022-07-28 | Tamara ZEKOVIC | Method for purifying recombinant viral particles |
| JP7683230B2 (ja) * | 2021-01-27 | 2025-05-27 | 東ソー株式会社 | アデノ随伴ウイルスの精製方法 |
| JP2022138144A (ja) * | 2021-03-09 | 2022-09-22 | Jcrファーマ株式会社 | 組換えaav9ビリオンの製造方法 |
| CN118202060A (zh) | 2021-10-05 | 2024-06-14 | 再生生物股份有限公司 | 用于重组aav生产的组合物和方法 |
| WO2023060113A1 (en) | 2021-10-05 | 2023-04-13 | Regenxbio Inc. | Compositions and methods for recombinant aav production |
| US20240408157A1 (en) | 2021-12-02 | 2024-12-12 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of fabry disease |
| CN114317464B (zh) * | 2021-12-27 | 2023-07-04 | 武汉汇研生物科技股份有限公司 | 腺相关病毒rAAV9的分离纯化方法 |
| US20250213727A1 (en) | 2022-03-25 | 2025-07-03 | Regenxbio Inc. | Dominant-negative tumor necrosis factor alpha adeno-associated virus gene therapy |
| US20230303983A1 (en) * | 2022-03-28 | 2023-09-28 | President And Fellows Of Harvard College | High efficiency purification of divergent aav serotypes using aavx affinity chromatography |
| WO2023239627A2 (en) | 2022-06-08 | 2023-12-14 | Regenxbio Inc. | Methods for recombinant aav production |
| WO2024015966A2 (en) | 2022-07-15 | 2024-01-18 | The Trustees Of The University Of Pennsylvania | Recombinant aav having aav clade d and clade e capsids and compositions containing same |
| WO2024038365A1 (en) * | 2022-08-16 | 2024-02-22 | Pfizer Inc. | Methods for purification of aav vectors by anion exchange chromatography |
| JP2026513932A (ja) | 2023-04-07 | 2026-05-01 | リジェネクスバイオ インコーポレイテッド | 組換えaav生成のための組成物及び方法 |
| EP4709866A2 (en) | 2023-05-07 | 2026-03-18 | REGENXBIO Inc. | Compositions and methods for recombinant aav production |
| CN121358762A (zh) * | 2023-05-23 | 2026-01-16 | 东曹株式会社 | 经修饰的重组腺相关病毒(aav)结合性蛋白质及aav的纯化方法 |
| WO2024243563A1 (en) * | 2023-05-25 | 2024-11-28 | Juno Therapeutics, Inc. | Aav purification method |
| WO2024263705A2 (en) * | 2023-06-20 | 2024-12-26 | Regeneron Pharmaceuticals, Inc. | Methods for purifying filled adeno-associated virus capsids |
| WO2025090962A1 (en) | 2023-10-25 | 2025-05-01 | Regenxbio Inc. | Compositions and methods for recombinant aav production |
| WO2025111473A1 (en) * | 2023-11-21 | 2025-05-30 | Regeneron Pharmaceuticals, Inc. | Covalently surface modified adeno-associated virus production by in vitro conjugation, and purification of covalently surface modified adeno-associated virus |
| EP4606892A1 (en) * | 2024-02-23 | 2025-08-27 | Merck Patent GmbH | Methods for the production of viral particles |
| WO2025226558A1 (en) * | 2024-04-22 | 2025-10-30 | Ultragenyx Pharmaceutical Inc. | Multi-step filtration and clarification methods for recombinant adeno-associated virus purification |
| WO2025228321A1 (en) * | 2024-04-29 | 2025-11-06 | Skyline Therapeutics (Shanghai) Co., Ltd. | METHOD OF SEPARATING RECOMBINANT ADENO-ASSOCIATED VIRUS (rAAV) PARTICLES |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003518380A (ja) | 1999-12-29 | 2003-06-10 | ジェンザイム・コーポレイション | 核酸および他の細胞性汚染混入物質からウイルスベクターを分離するための濾過助剤の使用方法 |
| WO2017100676A1 (en) | 2015-12-11 | 2017-06-15 | The Trustees Of The University Of Pennsylvania | Scalable purification method for aav8 |
| WO2017100674A1 (en) | 2015-12-11 | 2017-06-15 | The Trustees Of The University Of Pennsylvania | Scalable purification method for aav1 |
| WO2017160704A1 (en) | 2016-03-14 | 2017-09-21 | Perumala Corporation | Photovoltaic systems with intermittent and continuous recycling of light |
| WO2017160360A2 (en) | 2015-12-11 | 2017-09-21 | The Trustees Of The University Of Pennsylvania | Scalable purification method for aav9 |
| JP2018507707A (ja) | 2015-02-09 | 2018-03-22 | インスティチュート ナショナル デ ラ サンテ エ デ ラ ルシェルシュ メディカル (インセルム) | アフィニティー精製工程を含む組換えアデノ随伴ウイルス粒子の精製 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6995006B2 (en) | 1997-09-05 | 2006-02-07 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| US6596535B1 (en) | 1999-08-09 | 2003-07-22 | Targeted Genetics Corporation | Metabolically activated recombinant viral vectors and methods for the preparation and use |
| US6664305B2 (en) | 2000-06-27 | 2003-12-16 | Bia Separations D.O.O. | Chromatography material and a process of manufacturing that material |
| US6593123B1 (en) | 2000-08-07 | 2003-07-15 | Avigen, Inc. | Large-scale recombinant adeno-associated virus (rAAV) production and purification |
| US6723551B2 (en) | 2001-11-09 | 2004-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Production of adeno-associated virus in insect cells |
| CN103589692B (zh) | 2001-11-13 | 2018-07-24 | 宾夕法尼亚大学托管会 | 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法 |
| DK2359869T3 (en) | 2001-12-17 | 2019-04-15 | Univ Pennsylvania | Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof |
| JP4559429B2 (ja) | 2003-05-21 | 2010-10-06 | ジェンザイム・コーポレーション | 空キャプシドを実質的に含まない組換えaavビリオン調製物を生成するための方法 |
| EP1668143B1 (en) | 2003-09-30 | 2013-03-20 | The Trustees of The University of Pennsylvania | Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| US7183969B2 (en) | 2004-12-22 | 2007-02-27 | Raytheon Company | System and technique for calibrating radar arrays |
| DE23193606T1 (de) | 2005-04-07 | 2024-02-15 | The Trustees Of The University Of Pennsylvania | Verfahren zur erhöhung der funktion eines aav-vektors |
| JP4495210B2 (ja) | 2005-06-09 | 2010-06-30 | パナソニック株式会社 | 振幅誤差補償装置及び直交度誤差補償装置 |
| EP2242840B1 (en) | 2008-01-29 | 2019-07-24 | Applied Genetic Technologies Corporation | Recombinant adeno-associated virus production using bhk cells in suspension |
| AU2009215987B2 (en) | 2008-02-19 | 2015-01-22 | Uniqure Ip B.V. | Optimisation of expression of parvoviral rep and cap proteins in insect cells |
| DK2425000T3 (da) | 2009-04-30 | 2019-05-13 | Univ Pennsylvania | Sammensætninger rettet mod ledende luftvejsceller omfattende konstrukter af adeno-associeret virus |
| US8734809B2 (en) | 2009-05-28 | 2014-05-27 | University Of Massachusetts | AAV's and uses thereof |
| US8927514B2 (en) | 2010-04-30 | 2015-01-06 | City Of Hope | Recombinant adeno-associated vectors for targeted treatment |
| US8628966B2 (en) | 2010-04-30 | 2014-01-14 | City Of Hope | CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer |
| US10738326B2 (en) | 2010-10-27 | 2020-08-11 | Jichi Medical University | Adeno-associated virus vector for gene transfer to nervous system cells |
| CA2826273C (en) | 2011-02-10 | 2021-11-02 | The University Of North Carolina At Chapel Hill | Viral vectors with modified transduction profiles and methods of making and using the same |
| DK3693025T3 (da) | 2011-04-22 | 2022-01-10 | Univ California | Adenoassocierede virus-virioner med variant capsid og fremgangsmåder til anvendelse heraf |
| EP3795581A3 (en) | 2011-08-24 | 2021-06-09 | The Board of Trustees of the Leland Stanford Junior University | New avv capsid proteins for nucleic acid transfer |
| EP3470523A1 (en) | 2012-05-09 | 2019-04-17 | Oregon Health & Science University | Adeno associated virus plasmids and vectors |
| EP2970946A4 (en) | 2013-03-13 | 2016-09-07 | Philadelphia Children Hospital | ADENOASSOZED VIRUS VECTORS AND METHOD FOR USE THEREOF |
| US9862945B2 (en) | 2013-04-20 | 2018-01-09 | Research Institute At Nationwide Children's Hospital | Recombinant adeno-associated virus delivery of exon 2-targeted U7SNRNA polynucleotide constructs |
| NZ716102A (en) | 2013-07-22 | 2021-12-24 | The Children’S Hospital Of Philadelphia | Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues |
| EP3564379A1 (en) | 2013-09-13 | 2019-11-06 | California Institute of Technology | Selective recovery |
| HUE052676T2 (hu) | 2013-10-11 | 2021-05-28 | Massachusetts Eye & Ear Infirmary | Eljárások õsi vírusszekvenciák elõrejelzésére és alkalmazásaik |
| US10746742B2 (en) | 2014-04-25 | 2020-08-18 | Oregon Health & Science University | Methods of viral neutralizing antibody epitope mapping |
| US10577627B2 (en) | 2014-06-09 | 2020-03-03 | Voyager Therapeutics, Inc. | Chimeric capsids |
| WO2016049230A1 (en) | 2014-09-24 | 2016-03-31 | City Of Hope | Adeno-associated virus vector variants for high efficiency genome editing and methods thereof |
| JP6665466B2 (ja) | 2015-09-26 | 2020-03-13 | 日亜化学工業株式会社 | 半導体発光素子及びその製造方法 |
| WO2017070491A1 (en) | 2015-10-23 | 2017-04-27 | Applied Genetic Technologies Corporation | Ophthalmic formulations |
| EP3992283A1 (en) * | 2015-12-11 | 2022-05-04 | The Trustees Of The University Of Pennsylvania | Scalable purification method for aavrh10 |
| WO2019178495A1 (en) | 2018-03-16 | 2019-09-19 | Biogen Ma Inc. | Methods for purifying recombinant adeno-associated viruses |
| IL319002A (en) * | 2018-06-14 | 2025-04-01 | Regenxbio Inc | Anion exchange chromatography for recombinant AAV production |
-
2019
- 2019-06-13 IL IL319002A patent/IL319002A/en unknown
- 2019-06-13 WO PCT/US2019/037013 patent/WO2019241535A2/en not_active Ceased
- 2019-06-13 EP EP19748612.9A patent/EP3807405A2/en active Pending
- 2019-06-13 IL IL279193A patent/IL279193B2/en unknown
- 2019-06-13 CA CA3102817A patent/CA3102817A1/en active Pending
- 2019-06-13 JP JP2020568998A patent/JP7385603B2/ja active Active
- 2019-06-13 AU AU2019285186A patent/AU2019285186B2/en active Active
- 2019-06-13 KR KR1020217000909A patent/KR102930150B1/ko active Active
- 2019-06-13 US US17/251,869 patent/US12070702B2/en active Active
- 2019-06-13 CN CN201980048303.1A patent/CN112469822A/zh active Pending
-
2024
- 2024-07-19 US US18/777,913 patent/US20250186904A1/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003518380A (ja) | 1999-12-29 | 2003-06-10 | ジェンザイム・コーポレイション | 核酸および他の細胞性汚染混入物質からウイルスベクターを分離するための濾過助剤の使用方法 |
| JP2018507707A (ja) | 2015-02-09 | 2018-03-22 | インスティチュート ナショナル デ ラ サンテ エ デ ラ ルシェルシュ メディカル (インセルム) | アフィニティー精製工程を含む組換えアデノ随伴ウイルス粒子の精製 |
| WO2017100676A1 (en) | 2015-12-11 | 2017-06-15 | The Trustees Of The University Of Pennsylvania | Scalable purification method for aav8 |
| WO2017100674A1 (en) | 2015-12-11 | 2017-06-15 | The Trustees Of The University Of Pennsylvania | Scalable purification method for aav1 |
| WO2017160360A2 (en) | 2015-12-11 | 2017-09-21 | The Trustees Of The University Of Pennsylvania | Scalable purification method for aav9 |
| WO2017160704A1 (en) | 2016-03-14 | 2017-09-21 | Perumala Corporation | Photovoltaic systems with intermittent and continuous recycling of light |
Also Published As
| Publication number | Publication date |
|---|---|
| US20250186904A1 (en) | 2025-06-12 |
| IL279193B2 (en) | 2025-07-01 |
| IL279193B1 (en) | 2025-03-01 |
| IL319002A (en) | 2025-04-01 |
| WO2019241535A2 (en) | 2019-12-19 |
| IL279193A (en) | 2021-01-31 |
| AU2019285186A1 (en) | 2021-01-07 |
| EP3807405A2 (en) | 2021-04-21 |
| JP2021526829A (ja) | 2021-10-11 |
| KR102930150B1 (ko) | 2026-02-25 |
| US20210370199A1 (en) | 2021-12-02 |
| CN112469822A (zh) | 2021-03-09 |
| KR20210020100A (ko) | 2021-02-23 |
| CA3102817A1 (en) | 2019-12-19 |
| US12070702B2 (en) | 2024-08-27 |
| WO2019241535A3 (en) | 2020-01-23 |
| AU2019285186B2 (en) | 2025-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250186904A1 (en) | Anion exchange chromatography for recombinant aav production | |
| CN105861454B (zh) | 用于纯化重组aav载体的改进方法 | |
| KR20210043580A (ko) | 재조합 aav 생산을 위한 규모 조정 가능한 방법 | |
| EP3787771A1 (en) | Scalable clarification process for recombinant aav production | |
| US10626376B2 (en) | Method for isolating and purifying adeno-associated virus particles using salt | |
| JP2026513932A (ja) | 組換えaav生成のための組成物及び方法 | |
| JP2023554389A (ja) | 組換えアデノ随伴ウイルスウイルス粒子を生成する方法 | |
| JP2025535118A (ja) | Aavカプシドの精製のためのクロマトグラフィー方法 | |
| US11193112B2 (en) | Scalable process for oncolytic rat parvovirus H-1 production and purification based on isoelectric point-based elimination of empty particles | |
| JP2024503895A (ja) | 組換えポリペプチド及びウイルスの生成の改善 | |
| CN118006688A (zh) | 一种重组腺相关病毒载体的纯化方法 | |
| WO2024252182A1 (en) | Cation exchange chromatography for aav capture | |
| HK40014142A (en) | Scalable process for oncolytic rat parvovirus h-1 production and purification based on isoelectric point-based elimination of empty particles | |
| HK40014142B (en) | Scalable process for oncolytic rat parvovirus h-1 production and purification based on isoelectric point-based elimination of empty particles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210203 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220610 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220610 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230424 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230426 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230714 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230915 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20231023 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20231110 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7385603 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |